Review highlights machine learning's role in improving quality monitoring in pharmaceuticals, suggesting further integration with AI-IoT and blockchain.
This study reviews the use of machine learning (ML) for real-time quality monitoring of medicines and medical consumables. It explores various ML techniques—supervised, unsupervised, deep, and reinforcement learning—and their role in detecting defects, predicting anomalies, and optimizing processes. ML enhances accuracy and efficiency but faces challenges like data access, regulatory issues, and system integration. Emerging trends such as AI-IoT, blockchain, and federated learning offer promising advancements. The review provides insights into current practices, challenges, and future directions for ML-driven pharmaceutical quality monitoring.
No takes yet. Share an insight, caveat, or question.
Gavhane et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: